Unleashing the Power of Tregs
Multiple Treg therapeutic modalities addressing neurodegenerative, autoimmune, and metabolic diseases
We are a clinical-stage company focused on developing our multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Strong proof of concept data in Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s
Treg Enhancing Biologics:
Keep up-to-date with the latest news about Coya Therapeutics.